Article
Aberrant monocyte prostaglandin synthase 2 (PGS2) expression in type 1 diabetes before and after disease onset.
Pediatric diabetes - 1 Mar 2003
Litherland S A, She J X, Schatz D, Fuller K, Hutson A D, Peng R H, Li Y, Grebe K M, Whittaker D S, Bahjat K, Hopkins D, Fang Q, Spies P D, North K, Wasserfall C, Cook R, Dennis M A, Crockett S, Sleasman J, Kocher J, Muir A, Silverstein J, Atkinson M, Clare-Salzler M J
Abstract excerpt
METHODS: We examined monocyte prostaglandin synthase 2 (PGS2/COX2) expression in individuals at risk for or with type 1 diabetes including: (i) 58 established type 1 and 2 diabetic patients; (ii) 34 autoantibody positive (AA+) children and adults; (iii) 164 infants and young children with insulin-dependent diabetes mellitus (IDDM) susceptibility human leukocyte antigen (HLA) alleles; and (iv) 37 healthy control...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.